Source: http://www.fiercebiotech.com

Jecure Therapeutics: Versant's Jecure Therapeutics debuts with a focus on NASH, fibrosis

Read full article »
Jecure Therapeutics's Competitors | Jecure Therapeutics's News | Jecure Therapeutics's Financials
Stay up-to-date with the latest news on Jecure
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Jeffrey A. Stafford's photo - President & CEO of Jecure

President & CEO

Jeffrey A. Stafford

CEO Approval Rating

81/100

Read more
Stay up-to-date with the latest news on Jecure